Wound Fluid Matrix Metalloproteinase-9 as a Potential Predictive Marker for the Poor Healing Outcome in Diabetic Foot Ulcers
- PMID: 30410716
- PMCID: PMC6206565
- DOI: 10.1155/2018/1631325
Wound Fluid Matrix Metalloproteinase-9 as a Potential Predictive Marker for the Poor Healing Outcome in Diabetic Foot Ulcers
Abstract
Background and objective: Evidence for the roles of matrix metalloproteinases-9 (MMP-9) in the healing process of diabetic foot ulcers has remained unclear. We therefore aimed to demonstrate the relationship of MMP-9 with the wound healing process and determine its potential usefulness in predicting the wound healing outcome.
Methods: Twenty-two patients with diabetic foot ulcer were recruited. The wound size was determined, and the wound fluid was collected for the measurement of MMP-9 levels using an ELISA during the 12-week follow-up period regularly. The patients were categorized as good healers and poor healers when the wound area reduction was ≥ 50% and < 50% at week 4 when compared to the initial wound size at week 0.
Results: Median wound fluid MMP-9 levels in the poor healer group were shown to be significantly higher than those in the good healer group (1.03 pg/µg protein vs. 0.06 pg/µg protein, p = 0.001), and the levels fluctuated throughout the 12-week follow-up period. In contrast to the poor healer group, the MMP-9 levels were demonstrated to be constantly low throughout the follow-up period in the good healer group. ROC analysis showed that the MMP-9 level of 0.38 pg/µg protein was able to predict the wound healing outcome with the sensitivity of 81.8%, the specificity of 64.6%, and the area under the curve of 0.901 (CI 0.78-1.03, p = 0.001).
Conclusion: These findings suggested that determination of wound fluid MMP-9 levels might become a promising biomarker predicting wound healing outcomes and a novel potential therapeutic _target for diabetic foot ulcers.
Figures
Similar articles
-
Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.Diabet Med. 2008 Apr;25(4):419-26. doi: 10.1111/j.1464-5491.2008.02414.x. Diabet Med. 2008. PMID: 18387077 Free PMC article.
-
Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers.J Diabetes Complications. 2013 Jul-Aug;27(4):380-2. doi: 10.1016/j.jdiacomp.2012.12.007. Epub 2013 Jan 26. J Diabetes Complications. 2013. PMID: 23357650
-
An MMP/TIMP ratio scoring system as a potential predictive marker of diabetic foot ulcer healing.J Wound Care. 2018 Dec 2;27(12):849-855. doi: 10.12968/jowc.2018.27.12.849. J Wound Care. 2018. PMID: 30557113
-
[Research progress of dipeptidyl peptidase 4 inhibitors on healing of chronic diabetic foot ulcers].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018 May 15;32(5):630-633. doi: 10.7507/1002-1892.201802034. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018. PMID: 29806355 Free PMC article. Review. Chinese.
-
Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.Health Technol Assess. 2000;4(21):1-237. Health Technol Assess. 2000. PMID: 11074391 Review.
Cited by
-
Wound fluid sampling methods for proteomic studies: A scoping review.Wound Repair Regen. 2022 May;30(3):317-333. doi: 10.1111/wrr.13009. Epub 2022 Apr 5. Wound Repair Regen. 2022. PMID: 35381119 Free PMC article. Review.
-
Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers.Postepy Dermatol Alergol. 2021 Apr;38(2):230-234. doi: 10.5114/ada.2021.106201. Epub 2021 May 22. Postepy Dermatol Alergol. 2021. PMID: 34408591 Free PMC article.
-
_targeting Matrix Metalloproteinase-9 for Therapeutic Intervention in Diabetic Foot Ulcers.ACS Pharmacol Transl Sci. 2024 Jul 16;7(10):2901-2911. doi: 10.1021/acsptsci.4c00263. eCollection 2024 Oct 11. ACS Pharmacol Transl Sci. 2024. PMID: 39421656 Review.
-
Reepithelialization of Diabetic Skin and Mucosal Wounds Is Rescued by Treatment With Epigenetic Inhibitors.Diabetes. 2024 Jan 1;73(1):120-134. doi: 10.2337/db23-0258. Diabetes. 2024. PMID: 37874683 Free PMC article.
-
Investigating the microbial and metalloprotease sequestration properties of superabsorbent wound dressings.Sci Rep. 2022 Mar 19;12(1):4747. doi: 10.1038/s41598-022-08361-3. Sci Rep. 2022. PMID: 35306513 Free PMC article.
References
-
- Trengove N. J., Stacey M. C., Macauley S., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair and Regeneration: Official Publication of the Wound Healing Society and the European Tissue Repair Society. 1999;7(6):442–452. doi: 10.1046/j.1524-475X.1999.00442.x. - DOI - PubMed
-
- Yager D. R., Chen S. M., Ward S. I., Olutoye O. O., Diegelmann R. F., Cohen I. K. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair and Regeneration. 1997;5(1):23–32. doi: 10.1046/j.1524-475X.1997.50108.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous